Cited by 63Heavy Metal Exposure and ToxicityMercury impact and mitigation studiesVaccine Coverage and Hesitancy

Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.

Tozzi, Alberto Eugenio, Bisiacchi, Patrizia, Tarantino, Vincenza, De Mei, Barbara, D'Elia, Lidia, Chiarotti, Flavia, Salmaso, Stefania·2009·PEDIATRICS

Abstract

OBJECTIVE: Thimerosal, a mercury compound used as a preservative in vaccines administered during infancy, has been suspected to affect neuropsychological development. We compared the neuropsychological performance, 10 years after vaccination, of 2 groups of children exposed randomly to different amounts of thimerosal through immunization. METHODS: Children who were enrolled in an efficacy trial of pertussis vaccines in 1992-1993 were contacted in 2003. Two groups of children were identified, according to thimerosal content in vaccines assigned randomly in the first year of life (cumulative ethylmercury intake of 62.5 or 137.5 microg), and were compared with respect to neuropsychological outcomes. Eleven standardized neuropsychological tests, for a total of 24 outcomes, were administered to children during school hours. Mean scores of neuropsychological tests in the domains of memory and learning, attention, executive functions, visuospatial functions, language, and motor skills were compared according to thimerosal exposure and gender. Standard regression coefficients obtained through multivariate linear regression analyses were used as a measure of effect. RESULTS: Nearly 70% of the invited subjects participated in the neuropsychological assessment (N = 1403). Among the 24 neuropsychological outcomes that were evaluated, only 2 were significantly associated with thimerosal exposure. Girls with higher thimerosal intake had lower mean scores in the finger-tapping test with the dominant hand and in the Boston Naming Test. CONCLUSIONS: Given the large number of statistical comparisons performed, the few associations found between thimerosal exposure and neuropsychological development might be attributable to chance. The associations found, although statistically significant, were based on small differences in mean test scores, and their clinical relevance remains to be determined.

Integrity signals

Registry

Crossref · 10.1542/peds.2008-0795

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • When the safety of thimerosal as a vaccine component has been examined, it has not been found to have any associated risks, including no evidence of an increased risk of autism.

    “When the safety of thimerosal as a vaccine component has been examined, it has not been found to have any associated risks, including no evidence of an increased risk of autism (Tozzi et al., 2009; Price et al., 2010).”

    From Vaccine Safety: Myths and Misinformation (2020) · cites this paper as Tozzi et al., 2009

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tozzi, A. E., Bisiacchi, P., Tarantino, V., De Mei, B., D'Elia, L., Chiarotti, F., & Salmaso, S.
Affiliations
  • Bambino Gesù Children's Hospital (IT)
  • University of Padua (IT)
  • National Health Institute, Rome, Italy
Venue
PEDIATRICS
Published
2009-02-01
Volume
123
Issue
2
Pages
475-482
ISSN
  • 0031-4005 (ISSN-L)
  • 1098-4275
OpenAlex
W2145766615
Cited by
63
References
26
Citations by year
2026: 2 · 2025: 1 · 2023: 2 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 2 · 2014: 4 · 2013: 6 · 2012: 4
FWCI
6.40
Type
journal article
Language
en
Open access
closed
Locations
  • PEDIATRICS (publishedVersion)
  • PubMed (publishedVersion)
  • Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
  • Istituto Superiore di Sanità
  • Regione del Veneto
  • U.S. Public Health Service (2002-N-00448)
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Heavy Metal Exposure and Toxicity
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Mercury impact and mitigation studies
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
Keywords
thimerosal, ethylmercury, mercury exposure, infant immunization, vaccine preservatives, neuropsychological development, cognitive outcomes, pertussis vaccine, long-term follow-up, finger tapping test, Boston Naming Test, sex differences
MeSH terms
Child, Developmental Disabilities, Female, Humans, Infant, Male, Neuropsychological Tests, Preservatives, Pharmaceutical, Thimerosal, Time Factors, Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review